Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nanobiotix CEO Dr. Laurent Lévy is elected co-president of the French Technology Platform on Nanomedicine (FTPN)

Abstract:
Podcast available at www.medtechmatters.com

Nanobiotix CEO Dr. Laurent Lévy is elected co-president of the French Technology Platform on Nanomedicine (FTPN)

PARIS, France | Posted on June 4th, 2008

Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that its chief executive officer, Laurent Lévy, Ph.D., has been elected as co-president of the French Technology Platform on Nanomedicine (FTPN), effective immediately.

FTPN organizes communication, collaborative work and meetings among the French-based nanomedicine community's stakeholders—such as companies, research institutes, universities, hospitals, and patient associations—with representatives from ministries, regional clusters, government agencies and research foundations.

"I am honored to serve as the co-president of FTPN," said Dr. Lévy. "FTPN's mission is to help accelerate the development of nanomedicine into clinical practice for the benefit of patients. Moving forward, this evolving field of nanomedicine will be a great challenge, one that our committed board members are ready to undertake."

FTPN is the counterpart to the European Technology Platform on Nanomedicine (ETPN) and works to ensure French-based participation in European collaborative projects. Led by market needs and industrial developments, FTPN has the following goals: (1) identify and represent stakeholders; (2) support industrial R&D priorities and initiatives with a strong link and collaborative work with public-focused research; (3) allow emergence of innovative projects in accordance with national and local initiatives; (4) inform, and initiate dialogue with, patient associations and the general public; and (5) link and promote work between regulatory agencies and nanomedicine stakeholders. FTPN's board of directors includes—co-presidents: Dr. Lévy and Gérard Mathis, CSO, Cis-Bio; Patrice Marche representing INSERM and CNRS and Jean-Pierre Benoit representing clinical research; Patrick Boisseau, Executive Board member of the European Technology Platform on Nanomedicine; and, Pierre-Noël Lirsac, French representative to the European Technology Platform Nanomedicine Mirror Group1.

Nanomedicine2 is the application of nanotechnology to achieve breakthroughs in healthcare. It exploits the improved and often novel physical, chemical and biological properties of materials at the nanometer scale. Nanomedicine has the potential to enable early detection and prevention and to essentially improve diagnosis, treatment and follow-up of diseases.

1 Official representative from states member and associated states member from EU.

2 Source: ETPN, Strategic Research Agenda, November 2006.

####

About Nanobiotix
Nanobiotix is an emerging nanomedicine company combining dramatic advances in nanotechnology and molecular biology to develop nanoXray™— a technology platform that is expected to be turned ‘on’ and ‘off’ outside the body to selectively treat a variety of cancers safely and noninvasively. Use of nanoXray is intended to resolve radiation therapy’s biggest drawback: destruction of healthy tissue and its subsequent deleterious side effects when a high dose of Xray is necessary. The core of a nanoXray nanoparticle is an inactive and inert substance—not a drug—that can be activated to locally (intratumor) increase the dose of Xray, which is then expected to lead to higher efficiency. After nanoXray nanoparticles accumulate in the target tissues, a standard X-ray is applied that is intended to generate a local therapeutic effect, designed to destroy only the targeted tumor cells. This mechanism suggests total control of the intended therapeutic effect.

For more information, please click here

Contacts:
Ronald Trahan Associates Inc.
Ronald Trahan, APR
508-359-4005, x108

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern July 21st, 2018

World's fastest man-made spinning object could help study quantum mechanics July 20th, 2018

Relax, just break it July 20th, 2018

Future electronic components to be printed like newspapers July 20th, 2018

Nanomedicine

Nano-kirigami: 'Paper-cut' provides model for 3D intelligent nanofabrication July 13th, 2018

UMBC researchers develop nanoparticles to reduce internal bleeding caused by blast trauma July 13th, 2018

Researchers identify cost-cutting option in treating nail fungus with nanotechnology: GW researcher Adam Friedman, M.D., studied the potential use of nitric oxide-releasing nanoparticles to improve onychomycosis treatment July 11th, 2018

New sensor technology enables super-sensitive live monitoring of human biomolecules July 3rd, 2018

Announcements

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern July 21st, 2018

World's fastest man-made spinning object could help study quantum mechanics July 20th, 2018

Relax, just break it July 20th, 2018

Future electronic components to be printed like newspapers July 20th, 2018

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern July 21st, 2018

World's fastest man-made spinning object could help study quantum mechanics July 20th, 2018

Relax, just break it July 20th, 2018

Future electronic components to be printed like newspapers July 20th, 2018

Appointments/Promotions/New hires/Resignations/Deaths

Jim Barnhart Joins Nanometrics as Senior Vice President of Operations March 15th, 2018

Jonathan Chou to Join Nanometrics as Chief Financial Officer February 26th, 2018

Ocean Optics Grows Sales Organization with Executive Appointments: Henry Langston promoted, Christine Stannard joins spectral sensing product developer December 23rd, 2017

Emmanuel Sabonnadiere is Leti’s New CEO November 28th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project